Company

Taikang Life Insurance

泰康人寿

Taikang Life Insurance is a Chinese life insurer that has been active as a growth-stage equity investor, typically deploying capital through its asset-management arm, Taikang Asset. Its venture activity shows a preference for leading rounds in healthcare and enterprise-tech companies: it led the Series B for healthcare SaaS vendor Xiruan Technology in early 2022 , co-led or led Series C rounds in data infrastructure startup StartDT across 2021–2023 , and joined as a follower in community-grocery chain Qdama's 2019 Series D and Ruigu Mall's 2021–2022 funding spree . elsewhere's corpus does not contain a profile of the insurer itself—its founding date, AUM, or strategic mandate—only these deal footprints.

AI-generated — may contain errors, please verify.

Taikang Life InsuranceCompany
泰康人寿
渲染中…
Mentioned in 11 articles

Coverage